USRE48354E1 - Process for producing taurine from alkali taurinates - Google Patents

Process for producing taurine from alkali taurinates Download PDF

Info

Publication number
USRE48354E1
USRE48354E1 US16/854,395 US202016854395A USRE48354E US RE48354 E1 USRE48354 E1 US RE48354E1 US 202016854395 A US202016854395 A US 202016854395A US RE48354 E USRE48354 E US RE48354E
Authority
US
United States
Prior art keywords
alkali
sodium
tritaurinate
taurine
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
US16/854,395
Inventor
Songzhou Hu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vitaworks IP LLC
Original Assignee
Vitaworks IP LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54321417&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=USRE48354(E1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vitaworks IP LLC filed Critical Vitaworks IP LLC
Priority to US16/854,395 priority Critical patent/USRE48354E1/en
Application granted granted Critical
Publication of USRE48354E1 publication Critical patent/USRE48354E1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/32—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of salts of sulfonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/02—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/42—Separation; Purification; Stabilisation; Use of additives
    • C07C303/44—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
    • C07C309/14—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton

Definitions

  • the present invention relates to a cyclic process for the production of taurine from alkali isethionate and from alkali vinyl sulfonate in a high overall yield, i.e., greater than 90%, in particular, greater than 95%, by continuously converting the byproducts of the ammonolysis reaction, alkali ditaurinate and alkali tritaurinate, to alkali taurinate.
  • Taurine can be referred to as 2-aminoethanesulfonic acid and is one of the amino sulfonic acids found in the tissues of many animals. Taurine is an extremely useful compound because it has such pharmacological effects as detoxification effect, fatigue-relieving effect and nourishing and tonifying effect. As a result, taurine finds wide applications as an essential ingredient for human and animal nutrition.
  • Taurine is currently produced in an amount of over 50,000 tons per year from ethylene oxide and monoethanolamine. At present time, most of the taurine is produced from ethylene oxide, following a three-step process: (1) the addition reaction of ethylene oxide with sodium bisulfite to yield sodium isethionate; (2) the ammonolysis of sodium isethionate to yield sodium taurinate; (3) the neutralization with an acid, i.e, hydrochloric acid and, preferably, sulfuric acid, to generate taurine and inorganic salts.
  • an acid i.e, hydrochloric acid and, preferably, sulfuric acid
  • the ethylene oxide process is well established and widely practiced in commercial production, the overall yield is not very high, less than 80%. Moreover, the process generates a large amount of waste stream that is increasingly difficult to dispose of.
  • the first stage of the ethylene oxide process the addition reaction of ethylene oxide with sodium bisulfate, is known to yield sodium isethionate in high yield, practically quantitative, as disclosed in U.S. Pat. No. 2,820,818 under specified conditions.
  • U.S. Pat. No. 1,932,907 discloses that sodium taurinate is obtained in a yield of 80%, when sodium isethionate undergoes ammonolysis reaction in a molar ratio of 1:6.8 for 2 hrs at 240 to 250° C.
  • U.S. Pat. No. 1,999,614 describes the use of catalysts, i.e., sodium sulfate, sodium sulfite, and sodium carbonate, in the ammonolysis reaction.
  • a mixture of sodium taurinate and sodium ditaurinate is obtained in a yield as high as 97%. However, the percentage for sodium taurinate and sodium ditaurinate in the mixture is not specified.
  • DD 219 023 describes detailed results on the product distribution of the ammonolysis reaction of sodium isethionate.
  • sodium isethionate undergoes the ammonolysis reaction with 25% aqueous ammonia in a molar ratio of 1:9 at about 280° C. for 45 minutes in the presence of sodium sulfate and sodium hydroxide as catalyst, the reaction products comprise 71% of sodium taurinate and 29% of sodium di- and tri-taurinate.
  • WO 01/77071 is directed to a process for the preparation of ditaurine by heating an aqueous solution of sodium taurinate at a temperature of 210° C. in the presence of a reaction medium. A mixture of sodium taurinate and sodium ditaurinate is obtained.
  • ammonolysis of sodium isethionate invariably yields a mixture of sodium taurinate, sodium ditaurinate, and sodium tritaurinate.
  • the percentage yield of sodium taurinate has not been more than 80%.
  • U.S. Pat. No. 2,693,488 discloses a method of using ion exchange resins, first strongly acid ion exchange resin in hydrogen form, then an anion exchange resin in basic form. This process is complicated and requires the use of large quantity of acid and base to regenerate the ion exchange resins in each production cycle.
  • CN101508657, CN101508658, CN101508659, and CN101486669 describe a method of using sulfuric acid to neutralize sodium taurinate to obtain a solution of taurine and sodium sulfate. Crude taurine is easily obtained by filtration from a crystalline suspension of taurine after cooling. However, the waste mother liquor still contains taurine, sodium sulfate, and other unspecified organic impurities. It is desirable to have available a process for further separation of these components to achieve an economical process and to reduce the disposal of waste stream.
  • an object of the present invention to disclose a cyclic process for the production of taurine from alkali isethionate and from alkali vinyl sulfonate in a high overall yield, i.e., greater than 90%, in particular, greater than 95%.
  • sodium ditaurinate and sodium tritaurinate, byproducts from the ammonolysis of sodium isethionate or sodium vinyl sulfonate are continuously converted to sodium taurinate in the ammonolysis stage.
  • sodium ditaurinate and sodium tritaurinate are reacted with aqueous ammonia under ammonolysis reaction conditions, a mixture of similar compositions of sodium taurinate, ditaurinate, and tritaurinate is formed in an equilibrium state. This novel finding renders the cyclic process possible.
  • the residual taurine and sodium sulfate are separated from sodium ditaurinate and sodium tritaurinate by a process of co-crystallization of taurine and Glauber's salt at a temperature from 0 to 20° C.
  • the crystalline mixture of taurine and sodium sulfate is then separated from each other, while the mother liquor, consisting of taurine, monosodium ditaurinate, and monosodium tritauriante, is suitable for recycling to the ammonolysis step to prepare sodium taurinate.
  • FIG. 1 Schematic flowchart for the cyclic production of taurine from sodium isethionate and sodium vinyl sulfate.
  • FIG. 2 Solubility curves for taurine and sodium sulfate in water.
  • the present invention relates to a cyclic process for the production of taurine from alkali isethionate, which is a key intermediate for the ethylene oxide, ethanol, and ethylene processes.
  • This cyclic process is also applied to the production of taurine from alkali vinyl sulfonate, another intermediate for the ethanol and ethylene processes.
  • sodium isethionate and sodium vinyl sulfonate are preferably used, but other alkali metals, i.e., lithium, potassium, and cesium, are equally suitable.
  • alkali metals i.e., lithium, potassium, and cesium.
  • only sodium is used in replace of alkali metals to describe the process.
  • the present invention discloses a novel finding and process for converting sodium ditaurinate and sodium tritaurinate, byproducts of the ammonolysis of sodium isethionate, to sodium taurinate under the ammonolysis conditions.
  • sodium isethionate and sodium vinyl sulfonate are converted to sodium taurinate in a practically quantitative yield.
  • a complete separation of taurine with sodium sulfate according to the process in the present invention ensures that taurine is obtained in high yield, i.e., greater than 90%, in particular greater than 95% on the basis of sodium isethionate or sodium vinyl sulfonate.
  • the present invention describes a method for the preparation of pure sodium ditaurinate and pure sodium tritaurinate from diethanolamine and triethanolamine, respectively.
  • FIG. 1 describes the detailed unit operations for the cyclic process for the production and isolation of taurine from sodium isethionate.
  • the cycle is equally applicable for the production of taurine from sodium vinyl sulfonate.
  • catalysts are the alkaline salts of sodium, potassium and lithium.
  • Such salts are sodium hydroxide, potassium hydroxide, lithium hydroxide, sodium carbonate, potassium carbonate, lithium carbonate, sodium sulfate, sodium sulfite, potassium sulfate, potassium sulfite. Any one or a combination of two or more these salts can be used as catalyst to influence the reaction.
  • the strongly basic solution is neutralized with sulfuric acid to pH 5-7 to yield mainly taurine, sodium sulfate, sodium ditaurinate, and sodium tritaurinate.
  • the content of taurine and sodium sulfate is in a molar ratio of 1:0.5 to 1:0.6, and nearly the same in terms of their weight.
  • the initial solution is optionally concentrated, then cooled to 28 to 35° C., to crystallize taurine.
  • the first batch of crude taurine is obtained by filtration, while sodium sulfate remains in solution. Lower temperature is to be avoided to prevent the crystallization of sodium sulfate.
  • sodium sulfate has the maximum solubility at a temperature of 33° C. as shown in FIG. 2 .
  • the solubility of sodium sulfate decreases slightly from 33 to 100° C., but drastically from 33 to 0° C.
  • sodium sulfate crystallizes as anhydrous form above 40° C., but as Glauber's salt, i.e., sodium sulfate decahydrate at a temperature below 30° C.
  • the mother liquor is now consisted of about 30% of sodium sulfate and about 10% of taurine, along with various percentages of sodium ditaurinate and sodium tritaurinate.
  • This solution is concentrated to about one half to one third of its original volume in an evaporative crystallizer, at a temperature from 70 to 95° C., preferably 75 to 85° C., to yield a suspension of sodium sulfate, which is removed by filtration at the same temperature.
  • the temperature is kept high enough to prevent the crystallization of taurine at this stage.
  • the filtration mother liquor now saturated with sodium sulfate and rich in taurine, is cooled to 33-35° C. in the 1 st cooling crystallizer to crystallize the second crop of crude taurine.
  • the cycle of evaporative crystallization at higher temperature, preferably from 75 to 85° C., to remove sodium sulfate, and the first cooling crystallization at lower temperature, preferably at 33-35° C., can be continued until the solid content of impurities, mainly sodium ditaurinate and sodium tritaurinate, accumulates to about 30% of the solid content in the mother liquor.
  • the mother liquor from the first cooling crystallization stage can be returned to the ammonolysis step.
  • the mother liquor is cooled to 10 to 15° C. in the 2 nd cooling crystallizer to co-crystallize taurine and sodium sulfate decahydrate, i.e., Glauber's salt.
  • the co-crystalline mixture is removed from the mother liquor by centrifuge and returned to a dissolution and preheat unit for the evaporative crystallization step. It becomes apparent from FIG. 2 that lower temperature may be used, but excessive cooling is required to be economical. At higher temperature, removal of sodium sulfate is not complete.
  • the mother liquor from the second cooling crystallization stage is usually comprised of 25-30% of sodium ditaurinate and tritaurinate, 5-7% of taurine, and 7-8% of sodium sulfate.
  • Sodium hydroxide is then added in an amount sufficient to turn taurine to sodium taurinate, sodium ditaurinate to disodium ditaurinate, and disodium tritaurinate to trisodium tritaurinate.
  • the molar amount of sodium hydroxide is equal to, or slightly more than, the molar amount of total taurinates in the solution.
  • This solution is then saturated with ammonia to 15 to 28% and returned to the ammonolysis step.
  • this solution may be combined with a new batch of sodium isethionate or sodium vinyl sulfonate for the ammonolysis step.
  • the amount of purge solution in each cycle depends on the quality of starting materials, in particular, sodium isethionate and sodium vinyl sulfonate. If crude sodium isethionate in the ethylene oxide process is used, purge is required in about every five to eight cycles, because ethylene glycol, a byproduct from the reaction of ethylene oxide with water, starts to accumulate. If sodium isethionate is prepared from ethanol and ethylene, no purge is necessary at all.
  • Crude taurine obtained in the cyclic process is recrystallized from deionized water one or more times to yield a product of pharmaceutical grade.
  • the recrystallization mother liquor may be reused several times until it affects the quality of the product obtained.
  • This mother liquor consisting of residual taurine, sodium sulfate, and impurities, is then sent to dissolution and preheat unit for the evaporative crystallization.
  • the process according to the present invention can be carried out discontinuously, semi-continuously, and continuously.
  • This example relates to the preparation of sodium ditaurinate and its reaction with aqueous ammonia under ammonolysis reaction conditions.
  • the excess sodium sulfite is destroyed by addition of 40 mL of 30% hydrochloric acid, followed by careful adjustment of pH to 6-7 with sodium carbonate.
  • the solution consists of practically pure sodium ditaurinate and sodium chloride. The solution may be used directly in the ammonolysis reaction.
  • the aqueous solution is vacuum dried to give a white solid.
  • 600 mL of anhydrous methanol is added 600 mL of anhydrous methanol, and the suspension is refluxed for 30 minutes to dissolve sodium ditaurinate in methanol. After filtration to remove sodium chloride, the methanol solution is cooled to room temperature to crystallize pure sodium ditaurinate, which is used as analytical standard.
  • Crude sodium ditaurinate prepared from 0.30 mole of diethanolamine, is dissolved in 300 mL of water containing 26.0 g of sodium hydroxide. The solution is then mixed with 600 mL of 25% aqueous ammonia and heated in an autoclave at 220° C. for 2 hrs.
  • HPLC analysis of the reaction solution shows the formation of sodium taurinate (74%), sodium ditaurinate (24%), and sodium tritaurinate (2%) on the molar basis.
  • This example relates to the preparation of sodium tritaurinate and its reaction with aqueous ammonia under ammonolysis reaction conditions.
  • the crude reaction solution is transferred to a 2 L autoclave, to which 26 g of sodium hydroxide and 600 mL of 25% aqueous ammonia are added.
  • the autoclave is heated to 220° C. for 2 hrs to carry out the ammonolysis reaction.
  • This example demonstrates the conversion of sodium ditaurinate and sodium tritaurinate in the recrystallization mother liquor to sodium taurinate.
  • This example is directed to a process for the separation of taurine from sodium sulfate and from sodium ditaurinate and sodium tritaurinate.
  • a starting solution is prepared by first boiling the solution from the ammonolysis reaction to remove excess ammonia, and then adding enough sulfuric acid to pH 5-7.
  • the solution is consisted of 30% taurine, 26% sodium sulfate, and 7% sodium di- and tri-taurinates.
  • the separated mother liquor weighed 1580 g, is boiled to evaporate to 900 g to form a slurry of sodium sulfate. This slurry is cooled to 80° C. and filtered to recover sodium sulfate, weighed 304 g.
  • the mother liquor containing 202 g of taurine and 216 g of sodium sulfate, is cooled to 33° C. to form a second slurry of taurine. After filtration and washing with cold water, 124 g of taurine is obtained.
  • the mother liquor from the previous step now containing 78 of taurine and 216 g of sodium sulfate, is cooled to 10° C. in 2 hrs to obtain slurry of taurine and Glauber's salt.
  • the crystalline solid is obtained as a mixture of taurine and sodium sulfate decahydrate.
  • This final mother liquor about 500 g, is consisted of sodium ditaurinate and tritaurinate (28%, 140 g), taurine (24 g, 4.8%), and sodium sulfate (35 g, 7%). This solution is used for the ammonolysis reaction.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

A process for producing taurine from alkali ditaurinate or alkali tritaurinate, or their mixture, comprising the conversion of alkali ditaurinate to dialkali ditaurinate or alkali tritaurinate to trialkali tritaurinate, or their mixture, the ammonolysis reaction of ammonia added to a solution of dialkali ditaurinate or trialkali tritaurinate, or their mixture, to yield alkali taurinate, removing excess ammonia from the foregoing and neutralizing alkali taurinates with an acid to form a crystalline suspension of taurine, and recovering taurine by means of solid-liquid separation.

Description

More than one reissue application has been filed for U.S. Pat. No. 9,428,450, including U.S. application Ser. No. 16/843,272, filed Apr. 2, 2020, as well as U.S. application Ser. No. 16/854,395, filed Apr. 21, 2020, as well as U.S. application Ser. No. 16/854,406, filed Apr. 21, 2020. Each reissue application is a reissue application of U.S. Pat. No. 9,428,450.
TECHNICAL FIELD
The present invention relates to a cyclic process for the production of taurine from alkali isethionate and from alkali vinyl sulfonate in a high overall yield, i.e., greater than 90%, in particular, greater than 95%, by continuously converting the byproducts of the ammonolysis reaction, alkali ditaurinate and alkali tritaurinate, to alkali taurinate.
BACKGROUND OF THE INVENTION
Taurine can be referred to as 2-aminoethanesulfonic acid and is one of the amino sulfonic acids found in the tissues of many animals. Taurine is an extremely useful compound because it has such pharmacological effects as detoxification effect, fatigue-relieving effect and nourishing and tonifying effect. As a result, taurine finds wide applications as an essential ingredient for human and animal nutrition.
Taurine is currently produced in an amount of over 50,000 tons per year from ethylene oxide and monoethanolamine. At present time, most of the taurine is produced from ethylene oxide, following a three-step process: (1) the addition reaction of ethylene oxide with sodium bisulfite to yield sodium isethionate; (2) the ammonolysis of sodium isethionate to yield sodium taurinate; (3) the neutralization with an acid, i.e, hydrochloric acid and, preferably, sulfuric acid, to generate taurine and inorganic salts.
Although the ethylene oxide process is well established and widely practiced in commercial production, the overall yield is not very high, less than 80%. Moreover, the process generates a large amount of waste stream that is increasingly difficult to dispose of.
The first stage of the ethylene oxide process, the addition reaction of ethylene oxide with sodium bisulfate, is known to yield sodium isethionate in high yield, practically quantitative, as disclosed in U.S. Pat. No. 2,820,818 under specified conditions.
Therefore, the problems encountered in the production of taurine from the ethylene oxide process arise from the ammonolysis of sodium isethionate and from the separation of taurine from sodium sulfate.
According to the copending applications U.S. Ser. No. 13/999,203 and U.S. Ser. No. 13/999,439, these same issues are also encountered in the production of taurine from ethanol and ethylene, respectively. Sodium isethionate is a key common intermediate and the ammonolysis of sodium isethionate is an important step in the ethanol and ethylene processes.
U.S. Pat. No. 1,932,907 discloses that sodium taurinate is obtained in a yield of 80%, when sodium isethionate undergoes ammonolysis reaction in a molar ratio of 1:6.8 for 2 hrs at 240 to 250° C. U.S. Pat. No. 1,999,614 describes the use of catalysts, i.e., sodium sulfate, sodium sulfite, and sodium carbonate, in the ammonolysis reaction. A mixture of sodium taurinate and sodium ditaurinate is obtained in a yield as high as 97%. However, the percentage for sodium taurinate and sodium ditaurinate in the mixture is not specified.
DD 219 023 describes detailed results on the product distribution of the ammonolysis reaction of sodium isethionate. When sodium isethionate undergoes the ammonolysis reaction with 25% aqueous ammonia in a molar ratio of 1:9 at about 280° C. for 45 minutes in the presence of sodium sulfate and sodium hydroxide as catalyst, the reaction products comprise 71% of sodium taurinate and 29% of sodium di- and tri-taurinate.
WO 01/77071 is directed to a process for the preparation of ditaurine by heating an aqueous solution of sodium taurinate at a temperature of 210° C. in the presence of a reaction medium. A mixture of sodium taurinate and sodium ditaurinate is obtained.
From these prior arts, it is therefore concluded that the ammonolysis of sodium isethionate invariably yields a mixture of sodium taurinate, sodium ditaurinate, and sodium tritaurinate. The percentage yield of sodium taurinate has not been more than 80%.
In order to obtain taurine from sodium taurinate, U.S. Pat. No. 2,693,488 discloses a method of using ion exchange resins, first strongly acid ion exchange resin in hydrogen form, then an anion exchange resin in basic form. This process is complicated and requires the use of large quantity of acid and base to regenerate the ion exchange resins in each production cycle.
On the other hand, CN101508657, CN101508658, CN101508659, and CN101486669 describe a method of using sulfuric acid to neutralize sodium taurinate to obtain a solution of taurine and sodium sulfate. Crude taurine is easily obtained by filtration from a crystalline suspension of taurine after cooling. However, the waste mother liquor still contains taurine, sodium sulfate, and other unspecified organic impurities. It is desirable to have available a process for further separation of these components to achieve an economical process and to reduce the disposal of waste stream.
It is, therefore, an object of the present invention to disclose a cyclic process for the production of taurine from alkali isethionate and from alkali vinyl sulfonate in a high overall yield, i.e., greater than 90%, in particular, greater than 95%. According to the process in the present invention, sodium ditaurinate and sodium tritaurinate, byproducts from the ammonolysis of sodium isethionate or sodium vinyl sulfonate, are continuously converted to sodium taurinate in the ammonolysis stage.
It is another object of the present invention to disclose a process for the preparation of pure sodium ditaurinate and pure sodium tritaurinate, and their conversion to sodium taurinate. When sodium ditaurinate and sodium tritaurinate are reacted with aqueous ammonia under ammonolysis reaction conditions, a mixture of similar compositions of sodium taurinate, ditaurinate, and tritaurinate is formed in an equilibrium state. This novel finding renders the cyclic process possible.
It is a further object of the present invention to disclose a process for the complete separation of taurine and sodium sulfate from each other and from the byproducts, i.e., sodium ditaurinate and sodium tritaurinate. According to the process in the present invention, the residual taurine and sodium sulfate are separated from sodium ditaurinate and sodium tritaurinate by a process of co-crystallization of taurine and Glauber's salt at a temperature from 0 to 20° C. The crystalline mixture of taurine and sodium sulfate is then separated from each other, while the mother liquor, consisting of taurine, monosodium ditaurinate, and monosodium tritauriante, is suitable for recycling to the ammonolysis step to prepare sodium taurinate.
DESCRIPTION OF THE DRAWINGS
FIG. 1. Schematic flowchart for the cyclic production of taurine from sodium isethionate and sodium vinyl sulfate.
FIG. 2. Solubility curves for taurine and sodium sulfate in water.
 DESCRIPTION OF THE INVENTION
The present invention relates to a cyclic process for the production of taurine from alkali isethionate, which is a key intermediate for the ethylene oxide, ethanol, and ethylene processes. This cyclic process is also applied to the production of taurine from alkali vinyl sulfonate, another intermediate for the ethanol and ethylene processes.
For the production of taurine, sodium isethionate and sodium vinyl sulfonate are preferably used, but other alkali metals, i.e., lithium, potassium, and cesium, are equally suitable. In the drawings and following description, only sodium is used in replace of alkali metals to describe the process.
In order to achieve the cyclic process, the present invention discloses a novel finding and process for converting sodium ditaurinate and sodium tritaurinate, byproducts of the ammonolysis of sodium isethionate, to sodium taurinate under the ammonolysis conditions. According to the cyclic process in the present invention, sodium isethionate and sodium vinyl sulfonate are converted to sodium taurinate in a practically quantitative yield. A complete separation of taurine with sodium sulfate according to the process in the present invention ensures that taurine is obtained in high yield, i.e., greater than 90%, in particular greater than 95% on the basis of sodium isethionate or sodium vinyl sulfonate.
Although sodium ditaurinate and sodium tritaurinate are mentioned in the prior arts, preparation of pure products is not known. The present invention describes a method for the preparation of pure sodium ditaurinate and pure sodium tritaurinate from diethanolamine and triethanolamine, respectively.
To prepare sodium ditaurinate, diethanolamine is first reacted with excess thionyl chloride to form bis(2-chloroethyl)amine hydrochloride in quantitative yield, which undergoes sulfonation with sodium sulfite to yield the expected product. When triethanolamine is used in the same sequence of reactions, tris(2-chloroethyl)amine hydrochloride is obtained as an intermediate, disodium tritaurinate is obtained as an aqueous solution, along with sodium chloride. The reaction schemes are as follows:
Figure USRE048354-20201215-C00001
When sodium ditaurinate and sodium tritaurinate are subjected to the ammonolysis reaction in aqueous ammonia under the same conditions at a temperature of 220° C. for 2 hours, a mixture of similar compositions, i.e., sodium taurinate (74%), sodium ditaurinate (23%), and sodium tritaurinate (3%), is obtained. Clearly, an equilibrium state is reached among the three taurinates, irrespective of the starting materials.
This novel finding renders possible the cyclic process for preparing taurine from sodium isethionate and from sodium vinyl sulfonate, because the inevitable byproducts of the ammonolysis step, i.e., sodium ditaurinate and sodium tritaurinate, can be continuously converted to sodium taurinate in each successive cycle.
FIG. 1 describes the detailed unit operations for the cyclic process for the production and isolation of taurine from sodium isethionate. The cycle is equally applicable for the production of taurine from sodium vinyl sulfonate.
The cyclic process starts from the ammonolysis of sodium isethionate or sodium vinyl sulfonate in aqueous ammonia at a temperature of 150 to 270° C. under a pressure from the autogenous to 260 bars, and optionally, in the presence of catalysts. Usually, catalysts are the alkaline salts of sodium, potassium and lithium. Such salts are sodium hydroxide, potassium hydroxide, lithium hydroxide, sodium carbonate, potassium carbonate, lithium carbonate, sodium sulfate, sodium sulfite, potassium sulfate, potassium sulfite. Any one or a combination of two or more these salts can be used as catalyst to influence the reaction.
After the ammonolysis reaction, the excess ammonia are dispelled from the reaction solution and reclaimed for reuse. Sodium taurinate is obtained, along with sodium ditaurinate, sodium tritaurinate, and unreacted sodium isethionate.
The strongly basic solution is neutralized with sulfuric acid to pH 5-7 to yield mainly taurine, sodium sulfate, sodium ditaurinate, and sodium tritaurinate. The content of taurine and sodium sulfate is in a molar ratio of 1:0.5 to 1:0.6, and nearly the same in terms of their weight.
The initial solution is optionally concentrated, then cooled to 28 to 35° C., to crystallize taurine. The first batch of crude taurine is obtained by filtration, while sodium sulfate remains in solution. Lower temperature is to be avoided to prevent the crystallization of sodium sulfate.
It is important to point out that sodium sulfate has the maximum solubility at a temperature of 33° C. as shown in FIG. 2. The solubility of sodium sulfate decreases slightly from 33 to 100° C., but drastically from 33 to 0° C. Moreover, sodium sulfate crystallizes as anhydrous form above 40° C., but as Glauber's salt, i.e., sodium sulfate decahydrate at a temperature below 30° C.
The mother liquor is now consisted of about 30% of sodium sulfate and about 10% of taurine, along with various percentages of sodium ditaurinate and sodium tritaurinate. This solution is concentrated to about one half to one third of its original volume in an evaporative crystallizer, at a temperature from 70 to 95° C., preferably 75 to 85° C., to yield a suspension of sodium sulfate, which is removed by filtration at the same temperature. The temperature is kept high enough to prevent the crystallization of taurine at this stage.
The filtration mother liquor, now saturated with sodium sulfate and rich in taurine, is cooled to 33-35° C. in the 1st cooling crystallizer to crystallize the second crop of crude taurine.
The cycle of evaporative crystallization at higher temperature, preferably from 75 to 85° C., to remove sodium sulfate, and the first cooling crystallization at lower temperature, preferably at 33-35° C., can be continued until the solid content of impurities, mainly sodium ditaurinate and sodium tritaurinate, accumulates to about 30% of the solid content in the mother liquor.
The mother liquor from the first cooling crystallization stage can be returned to the ammonolysis step. Preferably, the mother liquor is cooled to 10 to 15° C. in the 2nd cooling crystallizer to co-crystallize taurine and sodium sulfate decahydrate, i.e., Glauber's salt. The co-crystalline mixture is removed from the mother liquor by centrifuge and returned to a dissolution and preheat unit for the evaporative crystallization step. It becomes apparent from FIG. 2 that lower temperature may be used, but excessive cooling is required to be economical. At higher temperature, removal of sodium sulfate is not complete.
The mother liquor from the second cooling crystallization stage is usually comprised of 25-30% of sodium ditaurinate and tritaurinate, 5-7% of taurine, and 7-8% of sodium sulfate. Sodium hydroxide is then added in an amount sufficient to turn taurine to sodium taurinate, sodium ditaurinate to disodium ditaurinate, and disodium tritaurinate to trisodium tritaurinate. In other words, the molar amount of sodium hydroxide is equal to, or slightly more than, the molar amount of total taurinates in the solution. This solution is then saturated with ammonia to 15 to 28% and returned to the ammonolysis step. Optionally, this solution may be combined with a new batch of sodium isethionate or sodium vinyl sulfonate for the ammonolysis step.
Some of the mother liquor from the 2nd cooling crystallization needs to be purged from the cycle, when uncharacterized impurities start to adversely influence the quality of the product. The amount of purge solution in each cycle depends on the quality of starting materials, in particular, sodium isethionate and sodium vinyl sulfonate. If crude sodium isethionate in the ethylene oxide process is used, purge is required in about every five to eight cycles, because ethylene glycol, a byproduct from the reaction of ethylene oxide with water, starts to accumulate. If sodium isethionate is prepared from ethanol and ethylene, no purge is necessary at all.
Crude taurine obtained in the cyclic process is recrystallized from deionized water one or more times to yield a product of pharmaceutical grade. The recrystallization mother liquor may be reused several times until it affects the quality of the product obtained. This mother liquor, consisting of residual taurine, sodium sulfate, and impurities, is then sent to dissolution and preheat unit for the evaporative crystallization.
It should be appreciated that no waste is generated in the cyclic process according to the present invention for the production of taurine from ethanol and ethylene, because sodium sulfate, discharged in the cyclic process, is recycled continuously to prepare sodium isethionate and sodium vinyl sulfonate.
The process according to the present invention can be carried out discontinuously, semi-continuously, and continuously.
EXAMPLES
The following examples will illustrate the practice of this invention but are not intended to limit its scope.
Example 1
This example relates to the preparation of sodium ditaurinate and its reaction with aqueous ammonia under ammonolysis reaction conditions.
Into a 1 L flask, equipped a refluxing condenser, is added 31.5 g (0.30 mole) of diethanolamine and 300 mL of dichloroethane, then 51.0 mL of thionyl chloride. Solid suspension formed immediately after the addition of thionyl chloride and then dissolved upon warming to 50° C. During refluxing, the solid suspension is dissolved and then the crystalline solid appears. The crystalline suspension is refluxed while being stirred for 3 hrs. The reaction is quenched by adding 20 mL of methanol and the solvents are removed under vacuum. A white crystalline material, bis(2-chloroethyl)amine hydrochloride, weighted 53.0 g, is obtained in a quantitative yield.
To the flask is added 500 mL of deionized water, 100 g of sodium sulfite. The solution is stirred at a temperature first at 50-60° C. for 3 hrs, then at 95° C. for 4 hrs. HPLC and LC-MS shows complete conversion of the starting material to the desired sodium ditaurinate.
The excess sodium sulfite is destroyed by addition of 40 mL of 30% hydrochloric acid, followed by careful adjustment of pH to 6-7 with sodium carbonate. The solution consists of practically pure sodium ditaurinate and sodium chloride. The solution may be used directly in the ammonolysis reaction.
To obtain pure sodium ditaurinate, the aqueous solution is vacuum dried to give a white solid. Into the flask is added 600 mL of anhydrous methanol, and the suspension is refluxed for 30 minutes to dissolve sodium ditaurinate in methanol. After filtration to remove sodium chloride, the methanol solution is cooled to room temperature to crystallize pure sodium ditaurinate, which is used as analytical standard.
Crude sodium ditaurinate, prepared from 0.30 mole of diethanolamine, is dissolved in 300 mL of water containing 26.0 g of sodium hydroxide. The solution is then mixed with 600 mL of 25% aqueous ammonia and heated in an autoclave at 220° C. for 2 hrs.
HPLC analysis of the reaction solution shows the formation of sodium taurinate (74%), sodium ditaurinate (24%), and sodium tritaurinate (2%) on the molar basis.
Example 2
This example relates to the preparation of sodium tritaurinate and its reaction with aqueous ammonia under ammonolysis reaction conditions.
Into a 1 L flask, equipped with a refluxing condenser, is added 29.8 g (0.20 mole) of triethanolamine, 300 mL of dichloroethane, then 51.0 mL of thionyl chloride. The mixture is heated to reflux for 4 hrs. The reaction is quenched by adding 20 mL of methanol. Removal of solvent gives a white crystalline mass of tris(2-chloroethylamine) hydrochloride in quantitative yield.
To the flask is added 500 mL of deionized water, 100 g of sodium sulfite. An oil phase is separated first. After heating at 60° C. for 2 hrs and 98° C. for 5 hrs, the oil phase disappears and a clear solution is obtained. HPLC and LC-MS shows complete conversion of the starting material to the desired sodium tritaurinate.
The crude reaction solution is transferred to a 2 L autoclave, to which 26 g of sodium hydroxide and 600 mL of 25% aqueous ammonia are added. The autoclave is heated to 220° C. for 2 hrs to carry out the ammonolysis reaction.
HPLC and LC-MS analysis shows that sodium tritaurinate is converted to a mixture of sodium taurinate (72%), sodium ditaurinate (23%), and sodium tritaurinate (5%) on the molar basis.
Example 3
This example demonstrates the conversion of sodium ditaurinate and sodium tritaurinate in the recrystallization mother liquor to sodium taurinate.
To 200 mL of the mother liquor from 2nd cooling crystallization stage, composed of sodium ditaurinate (25% by wt), sodium tritaurinate (3% by wt), taurine (5% by wt), and sodium sulfate (6% by wt), is added 15 g of sodium hydroxide, 500 mL of 25% aqueous ammonia. The solution is heated in a 2 L autoclave at 220° C. for 2 hrs to carry out the ammonolysis reaction.
HPLC and LC-MS analysis shows that the reaction solution is comprised of the following taurinates: sodium taurinate (76%), sodium ditaurinate (21%), and sodium tritaurinate (3%) on the molar basis.
Example 4
This example is directed to a process for the separation of taurine from sodium sulfate and from sodium ditaurinate and sodium tritaurinate.
A starting solution is prepared by first boiling the solution from the ammonolysis reaction to remove excess ammonia, and then adding enough sulfuric acid to pH 5-7. The solution is consisted of 30% taurine, 26% sodium sulfate, and 7% sodium di- and tri-taurinates.
2000 g of the starting solution is cooled from 80° C. to 33° C. to form a slurry consisting essentially of the first crop of crystallized taurine, which is separated by filtration at 33° C. and washed with 100 g of cold water. The recovered taurine is dried and weighed 398 g.
The separated mother liquor, weighed 1580 g, is boiled to evaporate to 900 g to form a slurry of sodium sulfate. This slurry is cooled to 80° C. and filtered to recover sodium sulfate, weighed 304 g.
The mother liquor, containing 202 g of taurine and 216 g of sodium sulfate, is cooled to 33° C. to form a second slurry of taurine. After filtration and washing with cold water, 124 g of taurine is obtained.
The mother liquor from the previous step, now containing 78 of taurine and 216 g of sodium sulfate, is cooled to 10° C. in 2 hrs to obtain slurry of taurine and Glauber's salt. The crystalline solid is obtained as a mixture of taurine and sodium sulfate decahydrate.
This final mother liquor, about 500 g, is consisted of sodium ditaurinate and tritaurinate (28%, 140 g), taurine (24 g, 4.8%), and sodium sulfate (35 g, 7%). This solution is used for the ammonolysis reaction.
It will be understood that the foregoing examples, explanation, drawings are for illustrative purposes only and that in view of the instant disclosure various modifications of the present invention will be self-evident to those skilled in the art and are to be included within the spirit and purview of this application and the scope of the appended claims.

Claims (14)

What is claimed is:
1. A process for the production of taurine from alkali ditaurinate or alkali tritaurinate, or their mixture, comprising,
(a) adding an alkali hydroxide to a solution of alkali ditaurinate, or alkali tritaurinate or their mixture, to prepare a solution of dialkali ditaurinate, or trialkali tritauriante or their mixture,
(b) adding an excess amount of ammonia to a solution of dialkali ditaurinate, or dialkali tritaurinate, or their mixture, and subjecting the solution to ammonolysis reaction to yield a mixture of alkali taurinates,
(c) removing excess ammonia from (b) and neutralizing alkali taurinates with an acid to form a crystalline suspension of taurine, and
(d) recovering taurine by means of solid-liquid separation.
2. The process according to claim 1, wherein alkali ditaurinate and alkali tritaurinate are prepared from diethanolamine and triethanolamine, respectively.
3. The process according to claim 1, wherein alkali ditaurinate, alkali tritaurinate, and their mixture are the byproducts in the production of taurine by the ammonolysis reaction of alkali isethionate or alkali vinyl sulfonate.
4. The process according to claim 1, wherein the catalysts for the ammonolysis reaction are sodium hydroxide, potassium hydroxide, lithium hydroxide, sodium carbonate, potassium carbonate, lithium carbonate, sodium sulfate, sodium sulfite, potassium sulfate, and potassium sulfite.
5. The process according to claim 1, wherein alkali metals are lithium, sodium, and potassium.
6. The process according to claim 1, wherein the acids are sulfuric acid, hydrochloric acid, nitric acid, hydrobromic acid, sulfurous acid, sulfur dioxide, and carbon dioxide.
7. The process according to claim 1, wherein the ammonolysis reaction is carried out at a temperature from 150 to 280° C. and under a pressure from autogenous to 260 bar.
8. A process for the production of taurine from alkali tritaurinate in an overall molar yield of at least 85% on the basis of alkali tritaurinate, comprising:
(a) adding an alkali hydroxide to a solution comprised of alkali tritaurinate to prepare a solution comprised of trialkali tritaurinate, wherein the molar amount of the alkali hydroxide is at least equal to the molar amount of total taurinates in the solution comprised of the alkali tritaurinate;
(b) adding excess ammonia to the solution comprised of the trialkali tritaurinate and subjecting the solution to ammonolysis;
(c) removing excess ammonia from the solution of step (b) and neutralizing the solution with an acid to form a crystalline suspension of taurine;
(d) recovering taurine by means of solid-liquid separation to obtain a mother liquor comprised of alkali ditaurinate and alkali tritaurinate, and
(e) returning the mother liquor of step (d) to step (a) as a solution comprised of alkali ditaurinate and alkali tritaurinate and performing the steps (a), (b), (c) and (d).
9. The process according to claim 8, wherein the alkali tritaurinate is prepared from triethanolamine.
10. The process according to claim 8, wherein the solution comprised of alkali tritaurinate is produced from alkali isethionate by a process comprising the steps of:
(1) adding excess ammonia to a solution comprised of alkali isethionate and subjecting the solution to ammonolysis;
(2) removing excess ammonia from the solution of step (1) and neutralizing the solution with an acid to yield a crystalline suspension of taurine; and
(3) recovering the taurine to yield a solution comprised of alkali ditaurinate and alkali tritaurinate.
11. The process according to claim 8, wherein the alkali metals are lithium, sodium, or potassium.
12. The process according to claim 8, wherein the acid is selected from the group consisting of sulfuric acid, hydrochloric acid, nitric acid, hydrobromic acid, sulfurous acid, sulfur dioxide, and carbon dioxide.
13. The process according to claim 8, wherein the ammonolysis reaction is carried out at a temperature from 150 to 280° C. and under a pressure from autogenous to 260 bar.
14. The process according to claim 8, wherein the solution comprised of alkali tritaurinate in step (a) further comprises alkali isethionate.
US16/854,395 2014-04-18 2020-04-21 Process for producing taurine from alkali taurinates Active USRE48354E1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US16/854,395 USRE48354E1 (en) 2014-04-18 2020-04-21 Process for producing taurine from alkali taurinates

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14/120,046 US9428450B2 (en) 2014-04-18 2014-04-18 Process for producing taurine from alkali taurinates
US16/854,395 USRE48354E1 (en) 2014-04-18 2020-04-21 Process for producing taurine from alkali taurinates

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US14/120,046 Reissue US9428450B2 (en) 2014-04-18 2014-04-18 Process for producing taurine from alkali taurinates

Publications (1)

Publication Number Publication Date
USRE48354E1 true USRE48354E1 (en) 2020-12-15

Family

ID=54321417

Family Applications (4)

Application Number Title Priority Date Filing Date
US14/120,046 Ceased US9428450B2 (en) 2014-04-18 2014-04-18 Process for producing taurine from alkali taurinates
US16/843,272 Active USRE48238E1 (en) 2014-04-18 2020-04-08 Process for producing taurine from alkali taurinates
US16/854,406 Active USRE48333E1 (en) 2014-04-18 2020-04-21 Process for producing taurine from alkali taurinates
US16/854,395 Active USRE48354E1 (en) 2014-04-18 2020-04-21 Process for producing taurine from alkali taurinates

Family Applications Before (3)

Application Number Title Priority Date Filing Date
US14/120,046 Ceased US9428450B2 (en) 2014-04-18 2014-04-18 Process for producing taurine from alkali taurinates
US16/843,272 Active USRE48238E1 (en) 2014-04-18 2020-04-08 Process for producing taurine from alkali taurinates
US16/854,406 Active USRE48333E1 (en) 2014-04-18 2020-04-21 Process for producing taurine from alkali taurinates

Country Status (9)

Country Link
US (4) US9428450B2 (en)
EP (2) EP3133060B1 (en)
JP (1) JP6405035B2 (en)
CN (3) CN105209431A (en)
CA (1) CA2946181C (en)
DK (1) DK3133060T3 (en)
ES (1) ES2728247T3 (en)
MX (1) MX2016013647A (en)
WO (1) WO2015158157A1 (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9145359B2 (en) 2013-12-30 2015-09-29 Songzhou Hu Cyclic process for the production of taurine from monoethanolamine
US20210179551A1 (en) 2014-04-18 2021-06-17 Vitaworks Ip, Llc Process for producing alkali taurinate
USRE48392E1 (en) 2014-04-18 2021-01-12 Vitaworks Ip, Llc Cyclic process for the production of taurine from alkali isethionate
US9573890B2 (en) 2014-04-18 2017-02-21 Vitaworks Ip, Llc Process for producing taurine
USRE48369E1 (en) 2014-04-18 2020-12-29 Vitaworks Ip, Llc Process for producing taurine
WO2018026396A1 (en) * 2016-08-04 2018-02-08 Vitaworks Ip, Llc Process for producing taurine
US9428450B2 (en) 2014-04-18 2016-08-30 Songzhou Hu Process for producing taurine from alkali taurinates
US9598357B1 (en) * 2016-02-29 2017-03-21 Vitaworks Ip, Llc Process for producing taurine from alkali taurinates
CN106008280B (en) * 2016-06-28 2018-01-09 潜江永安药业股份有限公司 A kind of method for preparing taurine
WO2018034696A1 (en) * 2016-08-16 2018-02-22 Vitaworks Ip, Llc Cyclic process for producing taurine
US10683264B2 (en) 2016-09-16 2020-06-16 Vitaworks Ip, Llc Process for producing taurine
US10112894B2 (en) 2016-09-16 2018-10-30 Vitaworks Ip, Llc Cyclic process for producing taurine
US9745258B1 (en) 2016-09-16 2017-08-29 Vitaworks Ip, Llc Cyclic process for producing taurine
US9815778B1 (en) 2016-09-16 2017-11-14 Vitaworks Ip, Llc Cyclic process for producing taurine
US10131621B2 (en) 2016-12-01 2018-11-20 Vitaworks Ip, Llc Process for recovering aminoalcohols and glycols from aqueous streams of taurine production
US9994517B1 (en) 2016-12-01 2018-06-12 Vitaworks Ip, Llc Method for preparing taurine
US9850200B1 (en) 2016-12-01 2017-12-26 Vitaworks Ip, Llc Method for preparing taurine
CN107056659B (en) * 2017-06-16 2019-06-18 潜江永安药业股份有限公司 A kind of method of high yield circulation production taurine
ES2942060T3 (en) * 2018-08-02 2023-05-29 Archer Daniels Midland Co Procedure for preparing products of biological origin from sugars
CN112010784B (en) * 2019-05-30 2021-07-20 浙江新和成股份有限公司 Preparation method of taurine intermediate sodium taurate and preparation method of taurine
CN110483342A (en) * 2019-09-02 2019-11-22 潜江永安药业股份有限公司 A kind of method and removal of impurities recovery system of taurine mother liquor removal of impurities recycling
CN110590613B (en) * 2019-10-16 2024-09-13 潜江永安药业股份有限公司 Method and production system for fully recycling taurine mother solution
CN112979508A (en) * 2019-12-18 2021-06-18 浙江新和成股份有限公司 Preparation method of taurine and recovery method of mother liquor of taurine
WO2021128220A1 (en) * 2019-12-26 2021-07-01 万华化学集团股份有限公司 Sodium taurate preparation method
CN111116430B (en) * 2019-12-26 2022-04-22 万华化学集团股份有限公司 Preparation method of sodium taurate
CN111471002B (en) 2020-04-22 2022-08-09 潜江永安药业股份有限公司 Method and system for preparing high-purity taurine and salt
US11161808B1 (en) 2020-09-09 2021-11-02 Vitaworks Ip, Llc Cyclic process for producing taurine from monoethanolamine
US11254639B1 (en) 2020-09-09 2022-02-22 Vitaworks Ip, Llc Cyclic process for producing taurine from monoethanolamine
US11578036B2 (en) 2020-09-09 2023-02-14 Vitaworks Ip, Llc Cyclic process for producing taurine from monoethanolamine
CN112979505B (en) 2021-03-04 2023-02-03 潜江永安药业股份有限公司 Method for preparing taurine
CN114349666B (en) * 2021-11-30 2022-12-06 浙江新和成药业有限公司 Preparation method of taurine
CN114315657B (en) 2021-12-24 2023-09-29 潜江永安药业股份有限公司 Method for recycling taurine mother liquor
CN114349667B (en) * 2022-01-13 2023-09-19 万华化学集团股份有限公司 Preparation method of disubstituted sodium taurate

Citations (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE219023C (en)
US1932907A (en) * 1931-06-22 1933-10-31 Ig Farbenindustrie Ag Process of preparing aminoalkylsulphonic acids
US1999614A (en) * 1932-02-12 1935-04-30 Gen Aniline Works Inc New process of preparing aminoalkylsulphonic acids
US2109401A (en) 1934-10-26 1938-02-22 Gen Aniline Works Inc Aminoalkyl-sulphonic acids and process of preparing them
US2693488A (en) 1950-08-30 1954-11-02 Dow Chemical Co Purification of amino alkane sulfonic acids by ion exchange
US2820818A (en) 1954-04-12 1958-01-21 Dow Chemical Co Preparation of salts of hydroxy aliphatic sulfonic acids
WO2001077071A1 (en) 2000-04-10 2001-10-18 Bayer Aktiengesellschaft Method for producing ditaurine and salts thereof
CN101486669A (en) * 2009-01-09 2009-07-22 沙洋天一药业有限公司 Method for synthesizing taurine
CN101508658A (en) * 2008-02-14 2009-08-19 王代龙 Method of preparing taurine
CN101508659A (en) * 2008-02-14 2009-08-19 王代龙 Method for preparing taurine
CN101508657A (en) * 2008-02-14 2009-08-19 王代龙 Synthesis of taurine
CN101717353A (en) 2009-11-11 2010-06-02 江苏远洋化学股份有限公司 Synthesis method of taurine
US8609890B1 (en) 2011-09-06 2013-12-17 Songzhou Hu Cyclic process for the production of taurine
US20140121405A1 (en) 2012-10-25 2014-05-01 Qianjiang Yongan Pharmaceutical Co., Ltd Process for producing taurine
US9061976B1 (en) 2014-05-27 2015-06-23 Songzhou Hu Cyclic process for the production of taurine from ethylene oxide
US20150210633A1 (en) 2014-01-29 2015-07-30 Songzhou Hu Process for the production of taurine from ethanol
CN104945289A (en) 2015-07-14 2015-09-30 潜江永安药业股份有限公司 Method for preparing taurine through solid isethionic acid sodium salt
US20150299113A1 (en) 2014-04-18 2015-10-22 Songzhou Hu Cyclic process for the production of taurine from alkali isethionate and alkali vinyl sulfonate
CN105693559A (en) 2015-12-29 2016-06-22 黄冈市富驰制药有限责任公司 Method for preparing taurine and co-producing bicarbonate
CN105732440A (en) 2016-03-21 2016-07-06 江阴华昌食品添加剂有限公司 Method of fully recycling mother liquid to produce taurine
US9428451B2 (en) 2014-04-18 2016-08-30 Songzhou Hu Cyclic process for the production of taurine from alkali isethionate
CN106008280A (en) 2016-06-28 2016-10-12 潜江永安药业股份有限公司 Taurine preparation method
US20160340300A1 (en) 2014-04-18 2016-11-24 Songzhou Hu Process for producing taurine
US20160355470A1 (en) 2014-04-18 2016-12-08 Songzhou Hu Cyclic process for producing taurine
US9598357B1 (en) 2016-02-29 2017-03-21 Vitaworks Ip, Llc Process for producing taurine from alkali taurinates
CN107056659A (en) 2017-06-16 2017-08-18 潜江永安药业股份有限公司 A kind of method of the production taurine of circulation in high yield
US9745258B1 (en) 2016-09-16 2017-08-29 Vitaworks Ip, Llc Cyclic process for producing taurine
US9815778B1 (en) 2016-09-16 2017-11-14 Vitaworks Ip, Llc Cyclic process for producing taurine
US9850200B1 (en) 2016-12-01 2017-12-26 Vitaworks Ip, Llc Method for preparing taurine
US20180093946A1 (en) 2016-09-16 2018-04-05 Vitaworks Ip, Llc Cyclic process for producing taurine
US20180155278A1 (en) 2016-12-01 2018-06-07 Vitaworks Ip, Llc Method for preparing taurine
US20180162806A1 (en) 2016-09-16 2018-06-14 Vitaworks Ip, Llc Process for producing taurine
US10131621B2 (en) 2016-12-01 2018-11-20 Vitaworks Ip, Llc Process for recovering aminoalcohols and glycols from aqueous streams of taurine production
US20190135739A1 (en) 2016-09-16 2019-05-09 Vitaworks Ip, Llc Process for producing taurine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD219023A3 (en) 1982-08-13 1985-02-20 Leuna Werke Veb PROCESS FOR THE PRODUCTION OF SODIUM TAURINATE
IL71357A (en) * 1983-03-29 1987-03-31 Union Carbide Corp Process for producing low density ethylene copolymers
CN102285905B (en) * 2011-07-05 2013-10-30 薛荔 Method for synthesizing taurine

Patent Citations (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE219023C (en)
US1932907A (en) * 1931-06-22 1933-10-31 Ig Farbenindustrie Ag Process of preparing aminoalkylsulphonic acids
US1999614A (en) * 1932-02-12 1935-04-30 Gen Aniline Works Inc New process of preparing aminoalkylsulphonic acids
US2109401A (en) 1934-10-26 1938-02-22 Gen Aniline Works Inc Aminoalkyl-sulphonic acids and process of preparing them
US2693488A (en) 1950-08-30 1954-11-02 Dow Chemical Co Purification of amino alkane sulfonic acids by ion exchange
US2820818A (en) 1954-04-12 1958-01-21 Dow Chemical Co Preparation of salts of hydroxy aliphatic sulfonic acids
WO2001077071A1 (en) 2000-04-10 2001-10-18 Bayer Aktiengesellschaft Method for producing ditaurine and salts thereof
CN101508658A (en) * 2008-02-14 2009-08-19 王代龙 Method of preparing taurine
CN101508659A (en) * 2008-02-14 2009-08-19 王代龙 Method for preparing taurine
CN101508657A (en) * 2008-02-14 2009-08-19 王代龙 Synthesis of taurine
CN101486669A (en) * 2009-01-09 2009-07-22 沙洋天一药业有限公司 Method for synthesizing taurine
CN101717353A (en) 2009-11-11 2010-06-02 江苏远洋化学股份有限公司 Synthesis method of taurine
US8609890B1 (en) 2011-09-06 2013-12-17 Songzhou Hu Cyclic process for the production of taurine
US20140121405A1 (en) 2012-10-25 2014-05-01 Qianjiang Yongan Pharmaceutical Co., Ltd Process for producing taurine
US9108907B1 (en) 2014-01-29 2015-08-18 Songzhou Hu Process for the production of taurine from ethanol
US20150210633A1 (en) 2014-01-29 2015-07-30 Songzhou Hu Process for the production of taurine from ethanol
US20160340300A1 (en) 2014-04-18 2016-11-24 Songzhou Hu Process for producing taurine
US20160355470A1 (en) 2014-04-18 2016-12-08 Songzhou Hu Cyclic process for producing taurine
US20150299113A1 (en) 2014-04-18 2015-10-22 Songzhou Hu Cyclic process for the production of taurine from alkali isethionate and alkali vinyl sulfonate
US20190112262A1 (en) 2014-04-18 2019-04-18 Vitaworks Ip, Llc Cyclic process for producing alkali taurinate
US20190112261A1 (en) 2014-04-18 2019-04-18 Vitaworks Ip, Llc Cyclic process for producing alkali taurinate
US9428450B2 (en) 2014-04-18 2016-08-30 Songzhou Hu Process for producing taurine from alkali taurinates
US9428451B2 (en) 2014-04-18 2016-08-30 Songzhou Hu Cyclic process for the production of taurine from alkali isethionate
US20180312464A1 (en) 2014-04-18 2018-11-01 Vitaworks Ip, Llc Process for producing alkali taurinate
US10040755B2 (en) 2014-04-18 2018-08-07 Vitaworks Ip, Llc Process for producing alkali taurinate
US20180141899A1 (en) 2014-04-18 2018-05-24 Vitaworks Ip, Llc Process for producing alkali taurinate
US9573890B2 (en) 2014-04-18 2017-02-21 Vitaworks Ip, Llc Process for producing taurine
US9593076B2 (en) 2014-04-18 2017-03-14 Vitaworks Ip, Llc Cyclic process for producing taurine
US9598360B2 (en) 2014-04-18 2017-03-21 Vitaworks Ip, Llc Cyclic process for production of taurine from alkali vinyl sulfonate
US20190112260A1 (en) 2014-04-18 2019-04-18 Vitaworks Ip, Llc Cyclic process for producing alkali taurinate
US9061976B1 (en) 2014-05-27 2015-06-23 Songzhou Hu Cyclic process for the production of taurine from ethylene oxide
CN104945289A (en) 2015-07-14 2015-09-30 潜江永安药业股份有限公司 Method for preparing taurine through solid isethionic acid sodium salt
CN105693559A (en) 2015-12-29 2016-06-22 黄冈市富驰制药有限责任公司 Method for preparing taurine and co-producing bicarbonate
US9598357B1 (en) 2016-02-29 2017-03-21 Vitaworks Ip, Llc Process for producing taurine from alkali taurinates
CN105732440A (en) 2016-03-21 2016-07-06 江阴华昌食品添加剂有限公司 Method of fully recycling mother liquid to produce taurine
CN106008280A (en) 2016-06-28 2016-10-12 潜江永安药业股份有限公司 Taurine preparation method
US20180093946A1 (en) 2016-09-16 2018-04-05 Vitaworks Ip, Llc Cyclic process for producing taurine
US9926265B1 (en) 2016-09-16 2018-03-27 Vitaworks Ip, Llc Cyclic process for producing taurine
US9815778B1 (en) 2016-09-16 2017-11-14 Vitaworks Ip, Llc Cyclic process for producing taurine
US20180162806A1 (en) 2016-09-16 2018-06-14 Vitaworks Ip, Llc Process for producing taurine
US9745258B1 (en) 2016-09-16 2017-08-29 Vitaworks Ip, Llc Cyclic process for producing taurine
US20190135739A1 (en) 2016-09-16 2019-05-09 Vitaworks Ip, Llc Process for producing taurine
US10112894B2 (en) 2016-09-16 2018-10-30 Vitaworks Ip, Llc Cyclic process for producing taurine
US9850200B1 (en) 2016-12-01 2017-12-26 Vitaworks Ip, Llc Method for preparing taurine
US10131621B2 (en) 2016-12-01 2018-11-20 Vitaworks Ip, Llc Process for recovering aminoalcohols and glycols from aqueous streams of taurine production
US9994517B1 (en) 2016-12-01 2018-06-12 Vitaworks Ip, Llc Method for preparing taurine
US20180155278A1 (en) 2016-12-01 2018-06-07 Vitaworks Ip, Llc Method for preparing taurine
US10071955B1 (en) 2017-06-16 2018-09-11 Qianjiang Yongan Pharmaceutical Co., Ltd. High-yield circular production method of taurine
CN107056659A (en) 2017-06-16 2017-08-18 潜江永安药业股份有限公司 A kind of method of the production taurine of circulation in high yield

Non-Patent Citations (81)

* Cited by examiner, † Cited by third party
Title
Bondavera et al., Pharmaceutical Chemistry Journal, Synthesis of Taurine, Mar. 2008, pp. 142-144, vol. 42, No. 3, Springer Science+Business Media, Inc, Secaucus, New Jersey.
Canadian First Office Action, dated Nov. 2, 2017 for corresponding Canada Application No. 2,946,181.
Curriculum Vitae (CV) of Robert E. Maleczka, as of Jul. 12, 2019, 39 pages, Vitaworks Exhibit 2008.
Database Caplus Chemical Abstracts Service, Columbus, Ohio, US; Database Accession No. 1986:34336, Abstract of DD 219023 Bach et al., Feb. 20, 1985. *
Database Caplus Chemical Abstracts Service, Columbus, Ohio, US; Database Accession No. 1993:233480, Abstract of JP 04352760, Dec. 7, 1992, Nippon Catalytic Chem Ind, Japan. *
Decision instituting inter partes review of U.S. Pat. No. 9,428,450, Proceeding IPR2018-01766, dated Apr. 9, 2019.
Decision re Institution of Inter Partes Review issued for Case IPR2018-01766 for corresponding U.S. Pat. No. 9,428,450, Dated Apr. 9, 2019, 45 pages.
Decision re Institution of Inter Partes Review issued for Case IPR2018-01767 for corresponding U.S. Pat. No. 9,428,451, dated Apr. 10, 2019, 25 pages.
Decision re Institution of Inter Partes Review issued for Case IPR2018-01768 for corresponding U.S. Pat. No. 9,573,890, dated Apr. 10, 2019, 23 pages.
Declaration of Joe P. Foley, Ph.D. in Support of Peitioner's Reply to Patent Owner'S Response, dated Oct. 7, 2019, 34 pages.
Declaration of Mark A. Lipton in Support of Peitioner's Reply to Patent Owner'S Response dated Oct. 7, 2019, 33 pages.
Declaration of Mark A. Lipton In Support of Petition for Inter Partes Review of U.S. Pat. No. 9,428,450 Under 37 C.F.R. § 42.100, Sep. 28, 2018, pp. 65.
Declaration of Mark A. Lipton In Support of Petition for Inter Partes Review of U.S. Pat. No. 9,428,451 Under 37 C.F.R. § 42.100, Sep. 28, 2018, pp. 69.
Declaration of Mark A. Lipton In Support of Petition for Inter Partes Review of U.S. Pat. No. 9,573,890 Under 37 C.F.R. § 42.100, Sep. 28, 2018, pp. 66.
Excerpts of File History of U.S. Appl. No. 14/120,046, which issued as U.S. Pat. No. 9,428,450, on Aug. 30, 2016.
Extended European Search Report and the European Search Opinion completed Apr. 5, 2017 for corresponding European Application No. 17157022.9.
Extended European Search Report issued by the European Patent Office for corresponding European Patent Application No. EP18154790.2, dated Jun. 25, 2018.
Final Office Action issued by the United States Patent and Trademark Office for corresponding U.S. Appl. No. 14/120,046, electronically delivered on Dec. 8, 2015.
Final Office Action issued by the United States Patent and Trademark Office for corresponding U.S. Appl. No. 16/030,605, electronically delivered on Jan. 30, 2019.
Final Written Decision for Inter Partes Review of U.S. Pat. No. 9,428,450, IPR2018-01766, dated Apr. 2, 2020, 65 pages.
Final Written Decision in inter partes review of U.S. Pat. No. 9,428,450, Proceeding IPR2018-01766, dated Apr. 2, 2020.
Fuming Liu, "Process Design of Taurine Ammonolysis," China Chemical Trade, No. 8: 120 (Aug. 2013).
Hubei Grand Life Science and Technology Co., Ltd v. Vitaworks IP, LLC, Case No. IPR2018-01766, Petition for Inter Parte Review of U.S. Pat. No. 9,428,450 Under 37 C.F.R. § 42.100, Sep. 28, 2018, pp. 80, Alexandria, Virginia.
Hubei Grand Life Science and Technology Co., Ltd v. Vitaworks IP, LLC, Case No. IPR2018-01767, Petition for Inter Parte Review of U.S. Pat. No. 9,428,451 Under 37 C.F.R. § 42.100, Sep. 28, 2018, pp. 88, Alexandria, Virginia.
Hubei Grand Life Science and Technology Co., Ltd v. Vitaworks IP, LLC, Case No. IPR2018-01768 Petition for Inter Parte Review of U.S. Pat. No. 9,573,890 Under 37 C.F.R. § 42.100, Sep. 28, 2018, pp. 82, Alexandria, Virginia.
International Search Report and Written Opinion for corresponding International Application No. PCT/US2017/018527, dated Jun. 8, 2017.
International Search Report for corresponding International Application No. PCT/CN2015/000232, dated Jul. 1, 2015.
Japanese Notice of Reasons for Rejection, dated Jun. 13, 2017 with English machine translation, for corresponding Japan application No. 2017-033759.
Jiang Wu & Zailin Guan, "Optimization on Ammonolysis in Manufacturing Method of Taurine", Journal of Hubei Polytechnic University, 19(1): 23-26 (Feb. 2004).
Journal of Hubei Institute of Technology, Opimization on Ammonolysis in Manufacturing Method of Taurine,Year 2004, pp. 23-26, vol. 19, No. 1, Sum No. 66, Editorial Department of Journal of Hubei Polytechnic University, Wuhan, China.
Letter to Judge Cecchi of NJ District Court regarding reissue office actions and protests filed in NJ District Court, Jul. 30, 2020, 3 pages.
Liu Fuming Process Design of the Ammonolysis Reaction of Taurine, China Chemical Trade, 2013, No. 8, pp. 120. (Original article is published in China in Chinese, an English translation by the Applicant is included).
Liu Fuming, China Chemical Trade, Process Design of Taurine, Year 2013, p. 120, vol. 5, No. 6, China National Chemical Center, Beijing City, China http://chemmedia.com.cn/GotoBin/Select.DLL.
Liu Fuming, Xie Liming Study on the Ammonolysis Reaction For Taurine, Shandong Chemical Industry, 2015, 44(5), pp. 27-28,30. (Origianl article is published in Chinese. An English translation by the Applicant is included).
Maleczka, R. E., Supplemental Declaration of Robert E. Maleczka, Jr., Ph.D., IPR2018-01766, Exhibit 2006, 9 pages, dated May 7, 2019.
Non-Final Office Action issued by the United States Patent and Trademark Office for corresponding U.S. Appl. No. 15/228,539, electronically delivered on Oct. 17, 2016.
Non-Final Office Action issued by the United States Patent and Trademark Office for corresponding U.S. Appl. No. 16/030,605, electronically delivered on Aug. 9, 2018.
Non-Final Office Action issued by the United States Patent and Trademark Office for corresponding U.S. Appl. No. 16/030,605, electronically delivered on Oct. 28, 2019.
Notice of Allowance issued by the United States Patent and Trademark Office for corresponding U.S. Appl. No. 14/120,046, electronically delivered on Jul. 14, 2016.
Notice of Allowance issued by the United States Patent and Trademark Office for corresponding U.S. Appl. No. 14/120,046, electronically delivered on May 24, 2016.
Notice of Allowance issued by the United States Patent and Trademark Office for corresponding U.S. Appl. No. 14/120,651, electronically delivered on Aug. 2, 2016.
Notice of Allowance issued by the United States Patent and Trademark Office for corresponding U.S. Appl. No. 15/228,539, electronically delivered on Dec. 23, 2016.
Notice of Allowance issued by the United States Patent and Trademark Office for corresponding U.S. Appl. No. 15/228,568, electronically delivered on Jan. 17, 2017.
Notice of Allowance issued by the United States Patent and Trademark Office for corresponding U.S. Appl. No. 15/238,621, electronically delivered on Jan. 4, 2017.
Notice of Allowance issued by the United States Patent and Trademark Office for corresponding U.S. Appl. No. 15/238,621, electronically delivered on Oct. 5, 2016.
Notice of Allowance, Reissue U.S. Appl. No. 16/843,272, dated Aug. 25, 2020, 12 pages.
Notice of Allowance, Reissue U.S. Appl. No. 16/854,406, dated Aug. 26, 2020, 12 pages.
Notification of Reasons for Rejection issued by the Japan Patent Office for corresponding Japanese Patent Application No. 2017-505693, dated Mar. 27, 2018, with an English translation.
Objective Indicia Exhibit A: Excerpt from "Bulletin of Ministry of Environment Protection of China", Jan. 27, 2015, with English summary, and excerpt from "Environment Impact Assessment Report of 25,000/Year Taurine Plant of Hubei Grand Life Science and Technology Co. Ltd.", dated Jul. 24, 2017, with English summary.
Objective Indicia Exhibit B: "Production Flowchart of Taurine in Environmental Impact Assessment Report of Jiangying Huachang Food Additive Company", 2005, with English translation of flowchart.
Objective Indicia Exhibit C: "Production Flowchart of Taurine in Amended Environmental Impact Assessment Report of Jiangying Huachang Food Additive Company", 2017, with English translation of flowchart.
Objective Indicia Exhibit D: Selected Pages from Qiangjiang Yongan Pharmaceutical Co. Annual Reports 2012-2015, with partial English translations.
Objective Indicia Exhibit G: "Study of the Ammonolysis Reaction for Taurine" Liu 2015; Liu Fuming & Xie Liming, Shandong Chemical Industry, May, 2015, vol. 44, No. 5, pp. 27-28, 30, with English translations.
Objective Indicia Exhibit H: Liu 2013, Liu Fuming, China Chemical Trade Monthly Journal, Aug. 2013, vol. 5, Issue. 8, HGL Exhibit 1019.
Objective Indicia Exhibit I: Wu 2004, Wu Jiang & Guan Zailin J. , Journal of Hubei Polytechnic University, Feb. 2004, vol. 19, No. 1, pp. 23-26, HGL Exhibit 1016.
Objective Indicia filed with Response dated Jul. 25, 2019, 11 pages.
Office Action issued by the Canadian Intellectual Property Office for corresponding Canadian Patent Application No. 2,946,181, dated Mar. 26, 2018.
Patent Owner's Preliminary Response for Inter Partes Review of U.S. Pat. No. 9,428,450 IPR2018-01766, dated Jan. 11, 2019, 50 pages.
Patent Owner's Preliminary Response for Inter Partes Review of U.S. Pat. No. 9,428,451 IPR2018-01767, dated Jan. 14, 2019, 62 pages.
Patent Owner's Preliminary Response for Inter Partes Review of U.S. Pat. No. 9,573,890 IPR2018-01768, dated Jan. 16, 2019, 54 pages.
Patent Owner's Response for Inter Partes Review of U.S. Pat. No. 9,428,450 IPR2018-01766, dated Jul. 12, 2019, 66 pages.
Patent Owner's Surreply for Inter Partes Review of U. S. Pat. No. 9,428,450, IPR2018-01766, dated Nov. 15, 2019, 33 pages.
Petition for inter partes review of U.S. Pat. No. 9,428,450, Proceeding IPR2018-01766, filed Sep. 28, 2018.
Petitioner's Reply to Patent Owner's Response for Inter Partes Review of U.S. Pat. No. 9,428,450, IPR2018-01766, dated Oct. 7, 2019, 38 pages.
Protest Under 37 C.F.R. 1.291(a) against Reissue U.S. Appl. No. 16/842,389, Jul. 28, 2020, 20 pages.
Protest Under 37 C.F.R. 1.291(a) against Reissue U.S. Appl. No. 16/843,272, Jul. 17, 2020, 14 pages.
Protest Under 37 C.F.R. 1.291(a) against Reissue U.S. Appl. No. 16/854,395, Jul. 17, 2020, 14 pages.
Protest Under 37 C.F.R. 1.291(a) against Reissue U.S. Appl. No. 16/854,406, Jul. 17, 2020, 14 pages.
Protest Under 37 C.F.R. 1.291(a) against Reissue U.S. Appl. No. 16/863,384, dated Aug. 3, 2020, 26 pages.
Results for experiments conducted between May 14, 2019 and Jun. 30, 2019, Vitaworks Exhibits 2009-2065.
Robert E. Maleczka's 2nd Declaration in Support of Patent Owner's Response for Inter Partes Review of U.S. Pat. No. 9,428,450, IPR2018-01766, dated Jul. 12, 2019, 81 pages, Vitaworks Exhibit 2007.
Robert E. Maleczka's Declaration in Support of Patent Owner's Preliminary Response for Inter Partes Review of U.S. Pat. No. 9,428,450 IPR2018-01766, dated Jan. 11, 2019, 60 pages.
Robert E. Maleczka's Declaration in Support of Patent Owner's Preliminary Response for Inter Partes Review of U.S. Pat. No. 9,428,451 IPR2018-01767, dated Jan. 14, 2019, 75 pages.
Robert E. Maleczka's Declaration in Support of Patent Owner's Preliminary Response for Inter Partes Review of U.S. Pat. No. 9,573,890 IPR2018-01768, dated Jan. 16, 2019, 67 pages.
Stipulation of Dismissal 2:17-cv-12358, Jun. 12, 2020, 1 page.
USPTO Non-Final Office Action for corresponding U.S. Appl. No. 14/120,046 dated Aug. 26, 2015.
USPTO Non-Final Office Action for corresponding U.S. Appl. No. 14/120,651 dated Mar. 15, 2016.
USPTO Non-Final Office Action for corresponding U.S. Appl. No. 15/228,539 dated Oct. 17, 2016.
USPTO Non-Final Office Action for corresponding U.S. Appl. No. 15/228,568 dated Oct. 5, 2016.
USPTO Non-Final Office Action for corresponding U.S. Appl. No. 15/870,844 dated May 10, 2018.
USPTO Notice of Allowance for corresponding U.S. Appl. No. 15/870,844 dated Jun. 15, 2018.

Also Published As

Publication number Publication date
CA2946181C (en) 2019-06-18
EP3133060A4 (en) 2018-02-21
EP3133060A1 (en) 2017-02-22
CN108314633A (en) 2018-07-24
US20150299113A1 (en) 2015-10-22
MX2016013647A (en) 2018-02-13
ES2728247T3 (en) 2019-10-23
JP6405035B2 (en) 2018-10-17
USRE48333E1 (en) 2020-12-01
JP2017533883A (en) 2017-11-16
DK3133060T3 (en) 2019-06-17
USRE48238E1 (en) 2020-10-06
CN105209431A (en) 2015-12-30
WO2015158157A1 (en) 2015-10-22
CA2946181A1 (en) 2015-10-22
EP3351529A1 (en) 2018-07-25
US9428450B2 (en) 2016-08-30
CN108314634A (en) 2018-07-24
EP3133060B1 (en) 2019-03-13

Similar Documents

Publication Publication Date Title
USRE48333E1 (en) Process for producing taurine from alkali taurinates
US9598360B2 (en) Cyclic process for production of taurine from alkali vinyl sulfonate
USRE49370E1 (en) Cyclic process for the production of taurine from monoethanolamine
US9745258B1 (en) Cyclic process for producing taurine
US9815778B1 (en) Cyclic process for producing taurine
US9061976B1 (en) Cyclic process for the production of taurine from ethylene oxide
US9573890B2 (en) Process for producing taurine
US9850200B1 (en) Method for preparing taurine
US10112894B2 (en) Cyclic process for producing taurine
US20180162806A1 (en) Process for producing taurine
JP2017206495A (en) Method for producing taurine from alkali taurinate
US11845714B2 (en) Process for producing taurine
WO2018141642A1 (en) Process for the preparation of 2-chloro-4-fluoro-5-nitrobenzotrichloride
JP2018021003A (en) Method for producing taurine
USRE48392E1 (en) Cyclic process for the production of taurine from alkali isethionate
USRE48369E1 (en) Process for producing taurine
EP1491528A1 (en) Process for producing 4,4-bisphenol sulfone
JPH06345717A (en) Method for purifying aminoethanesulfonates

Legal Events

Date Code Title Description
FEPP Fee payment procedure

Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

FEPP Fee payment procedure

Free format text: ENTITY STATUS SET TO SMALL (ORIGINAL EVENT CODE: SMAL); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2552); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

Year of fee payment: 8